ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model

Optimal candidate for microbicide combinations

Ana C G Tuyama, Natalia V. Cheshenko, Maria J. Carlucci, Jin Hua Li, Cindy L. Goldberg, Donald P. Waller, Robert A. Anderson, Albert T. Profy, Mary E. Klotman, Marla J. Keller, Betsy Herold

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The acidic vaginal milieu is presumed to inactivate pathogens but is neutralized by semen. This notion fostered the development of acid-buffering products, such as ACIDFORM (developed by Program for Topical Prevention of Conception and Disease, Rush University, and licensed by Instead), as microbicides. However, the extent and mechanism of protective activity provided by buffering gels is not known. Exposure of herpes simplex virus (HSV) to pH 4.5 or lower irreversibly inactivated HSV and reduced HSV yields by at least 90%; exposure to pH 5.0 had little or no effect. Pretreatment of HSV-2 with pH 3.5-4.5 triggered proteolysis, disrupting the HSV particle and resulting in a reduction in binding and invasion. ACIDFORM protected 21 (81%) of 26 mice from genital herpes, compared with 3 (12%) of 25 mice who received a placebo gel. ACIDFORM retained significant activity if mice were challenged with HSV delivered in seminal fluid. These findings suggest that ACIDFORM offers considerable protection against HSV and may be an optimal candidate for developing combination microbicides.

Original languageEnglish (US)
Pages (from-to)795-803
Number of pages9
JournalJournal of Infectious Diseases
Volume194
Issue number6
DOIs
StatePublished - Sep 15 2006
Externally publishedYes

Fingerprint

Herpes Genitalis
Simplexvirus
Anti-Infective Agents
Gels
Human Herpesvirus 2
Semen
Virion
Proteolysis
Placebos
Acids

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model : Optimal candidate for microbicide combinations. / Tuyama, Ana C G; Cheshenko, Natalia V.; Carlucci, Maria J.; Li, Jin Hua; Goldberg, Cindy L.; Waller, Donald P.; Anderson, Robert A.; Profy, Albert T.; Klotman, Mary E.; Keller, Marla J.; Herold, Betsy.

In: Journal of Infectious Diseases, Vol. 194, No. 6, 15.09.2006, p. 795-803.

Research output: Contribution to journalArticle

Tuyama, Ana C G ; Cheshenko, Natalia V. ; Carlucci, Maria J. ; Li, Jin Hua ; Goldberg, Cindy L. ; Waller, Donald P. ; Anderson, Robert A. ; Profy, Albert T. ; Klotman, Mary E. ; Keller, Marla J. ; Herold, Betsy. / ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model : Optimal candidate for microbicide combinations. In: Journal of Infectious Diseases. 2006 ; Vol. 194, No. 6. pp. 795-803.
@article{e10d8a5f3ea244ffb894fcf90267e3f2,
title = "ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: Optimal candidate for microbicide combinations",
abstract = "The acidic vaginal milieu is presumed to inactivate pathogens but is neutralized by semen. This notion fostered the development of acid-buffering products, such as ACIDFORM (developed by Program for Topical Prevention of Conception and Disease, Rush University, and licensed by Instead), as microbicides. However, the extent and mechanism of protective activity provided by buffering gels is not known. Exposure of herpes simplex virus (HSV) to pH 4.5 or lower irreversibly inactivated HSV and reduced HSV yields by at least 90{\%}; exposure to pH 5.0 had little or no effect. Pretreatment of HSV-2 with pH 3.5-4.5 triggered proteolysis, disrupting the HSV particle and resulting in a reduction in binding and invasion. ACIDFORM protected 21 (81{\%}) of 26 mice from genital herpes, compared with 3 (12{\%}) of 25 mice who received a placebo gel. ACIDFORM retained significant activity if mice were challenged with HSV delivered in seminal fluid. These findings suggest that ACIDFORM offers considerable protection against HSV and may be an optimal candidate for developing combination microbicides.",
author = "Tuyama, {Ana C G} and Cheshenko, {Natalia V.} and Carlucci, {Maria J.} and Li, {Jin Hua} and Goldberg, {Cindy L.} and Waller, {Donald P.} and Anderson, {Robert A.} and Profy, {Albert T.} and Klotman, {Mary E.} and Keller, {Marla J.} and Betsy Herold",
year = "2006",
month = "9",
day = "15",
doi = "10.1086/506948",
language = "English (US)",
volume = "194",
pages = "795--803",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model

T2 - Optimal candidate for microbicide combinations

AU - Tuyama, Ana C G

AU - Cheshenko, Natalia V.

AU - Carlucci, Maria J.

AU - Li, Jin Hua

AU - Goldberg, Cindy L.

AU - Waller, Donald P.

AU - Anderson, Robert A.

AU - Profy, Albert T.

AU - Klotman, Mary E.

AU - Keller, Marla J.

AU - Herold, Betsy

PY - 2006/9/15

Y1 - 2006/9/15

N2 - The acidic vaginal milieu is presumed to inactivate pathogens but is neutralized by semen. This notion fostered the development of acid-buffering products, such as ACIDFORM (developed by Program for Topical Prevention of Conception and Disease, Rush University, and licensed by Instead), as microbicides. However, the extent and mechanism of protective activity provided by buffering gels is not known. Exposure of herpes simplex virus (HSV) to pH 4.5 or lower irreversibly inactivated HSV and reduced HSV yields by at least 90%; exposure to pH 5.0 had little or no effect. Pretreatment of HSV-2 with pH 3.5-4.5 triggered proteolysis, disrupting the HSV particle and resulting in a reduction in binding and invasion. ACIDFORM protected 21 (81%) of 26 mice from genital herpes, compared with 3 (12%) of 25 mice who received a placebo gel. ACIDFORM retained significant activity if mice were challenged with HSV delivered in seminal fluid. These findings suggest that ACIDFORM offers considerable protection against HSV and may be an optimal candidate for developing combination microbicides.

AB - The acidic vaginal milieu is presumed to inactivate pathogens but is neutralized by semen. This notion fostered the development of acid-buffering products, such as ACIDFORM (developed by Program for Topical Prevention of Conception and Disease, Rush University, and licensed by Instead), as microbicides. However, the extent and mechanism of protective activity provided by buffering gels is not known. Exposure of herpes simplex virus (HSV) to pH 4.5 or lower irreversibly inactivated HSV and reduced HSV yields by at least 90%; exposure to pH 5.0 had little or no effect. Pretreatment of HSV-2 with pH 3.5-4.5 triggered proteolysis, disrupting the HSV particle and resulting in a reduction in binding and invasion. ACIDFORM protected 21 (81%) of 26 mice from genital herpes, compared with 3 (12%) of 25 mice who received a placebo gel. ACIDFORM retained significant activity if mice were challenged with HSV delivered in seminal fluid. These findings suggest that ACIDFORM offers considerable protection against HSV and may be an optimal candidate for developing combination microbicides.

UR - http://www.scopus.com/inward/record.url?scp=33748419209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748419209&partnerID=8YFLogxK

U2 - 10.1086/506948

DO - 10.1086/506948

M3 - Article

VL - 194

SP - 795

EP - 803

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -